The long-sought discovery of HER2 as an actionable and highly sensitive therapeutic target was a major breakthrough for the treatment of highly aggressive HER2-positive breast cancer, leading to approval of the first HER2-targeted drug — the monoclonal antibody trastuzumab — almost 25 years ago....
Four researchers from the USA Health Mitchell Cancer Institute and the Frederick P. Whiddon College of Medicine at the University of South Alabama recently were awarded grants from the Breast Cancer Research Foundation of Alabama (BCRFA). Presented during an event in Birmingham last December, the a...
Breast cancer is now globally the most frequent cancer and leading cause of women’s death. Two thirds of breast cancers express the luminal estrogen receptor-positive (ERα + ) phenotype that is initially responsive to antihormonal therapies, but drug resistance emerges. A major barrier to...
AstraZeneca oncology R&D executive vice-president José Baselga said: “Trastuzumab deruxtecan has the potential to transform the treatment landscape for patients with HER2-positive metastatic breast cancer who have limited treatment options today. “This priority review draws on the strength and the c...
Grants to Help Immigrants Fight Breast CancerByline: Victoria Pierce Daily Herald Staff Writer Language and cultural barriers can put...Pierce, Victoria
Financial Disclosures: Dr Shu reports having received a research development fund from the United Soybean Board in 2005. No other disclosures were reported. Funding/Support: This study was supported by grants from the US Department of Defense Breast Cancer Research Program (grant DAMD 17-02-1-0607...
Financial Assistance Don’t let financial hardship keep you from getting the treatment you need. The Financial Assistance Program is here to help so you can focus on your care. Breast Cancer Answers Information & Resources Find the latest information on breast cancer risk factors, screening, diagno...
There is little evidence that dietary supplements are beneficial for patients with breast cancer; therefore, they are usually not recommended by treatment guidelines. The aim of the present analysis was to assess the prevalence of dietary supplement (DS) intake among women before and after a breast...
Dr Chelmow reported serving as chair of the American College of Obstetricians and Gynecologists Practice Advisory Committee; in this role, he was involved in the development of practice guidelines related to breast cancer screening. Dr Barry reported receiving grants from Healthwise, a nonprofit, out...
Figure 2. Incidence of Breast Cancer in Women With Schizophrenia View LargeDownload Pooled results of 12 cohorts indicated that schizophrenia was associated with a significantly increased risk of breast cancer incidence in women. IV indicates inverse variance; SIR, standardized incidence ratio. Figure ...